| Product NDC: | 0069-3220 |
| Proprietary Name: | Feldene |
| Non Proprietary Name: | PIROXICAM |
| Active Ingredient(s): | 10 mg/1 & nbsp; PIROXICAM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0069-3220 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018147 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19940525 |
| Package NDC: | 0069-3220-66 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (0069-3220-66) |
| NDC Code | 0069-3220-66 |
| Proprietary Name | Feldene |
| Package Description | 100 CAPSULE in 1 BOTTLE (0069-3220-66) |
| Product NDC | 0069-3220 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PIROXICAM |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19940525 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | PIROXICAM |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |